Antiviral therapy using thiazine and xanthene dyes
CA 2055463 C · Owner: Oklahoma Medical Research Foundation · Inventors: Schinazi, Raymond F.; Floyd, Robert A.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method for using thiazine and xanthene dyes to selectively inactivate or inhibit intracellular replication of specific viruses, especially human immunodeficiency virus. Examples of useful xanthine dyes are rose bengal and eosin Y. A preferred thiazine dye is methylene blue. The dyes interfere with transcription and translation of viral nucleic acid. Light penetrating the skin to the capillaries at the surface can be used to enhance the activity of the dye.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 11, 1990 and granted September 30, 1997. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended May 11, 2010.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 11, 2012.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.